Health ❯Clinical Trials

Cancer Research

Therapeutic Strategies Therapeutic Approaches Treatment Innovations Patient Treatment Preventative Medicine Blood Tests Melanoma Stem Cell Research Survival Rates

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma

NYU Langone Health researchers link the HG-T variant to weakened T cell responses with plans to test haplogroup-guided immunotherapy.

Anti-CD30 therapy restores PD-1 immunotherapy efficacy in resistant skin cancers

AI Blood Test ARTEMIS-DELFI Revolutionizes Pancreatic Cancer Treatment Monitoring

New Bone Marrow Test Doubles Survival for Some AML Patients, Study Confirms

Severe COVID Immune Response Found to Shrink Tumors in Mice

Merck-Moderna Vaccine Reduces Risk of Severe Melanoma Relapse by Half